Mesa Labs Inc (MLAB) Stock Price, Quote & News

Company Profile

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also pro...

Industry: Scientific & Technical Instruments

Sector: Technology

Phone: 303 987 8000

Website: www.mesalabs.com

Address:

12100 West Sixth Avenue, Lakewood, United States

d_risk Jun. 4 at 2:38 PM

$MLAB - Mesa Laboratories Inc - 10K - Updated Risk Factors MLAB flags heightened exposure to global macro and geopolitical volatility, supply chain and tariff pressures, intensifying competition and consolidation, execution risk from cost-cutting and international expansion, CEO transition uncertainty, emerging AI and cybersecurity/privacy liabilities, concentration risk in dialysis calibration products, and vulnerability to catastrophic events outstripping insurance. #MedicalDevices #SupplyChainRisk #GeopoliticalVolatility #AILiability #MarketConsolidation 🟢 Added 🟠 Removed https://d-risk.ai/MLAB/10-K/2026-06-02

0 · Reply

Quadruple_Double Jun. 1 at 4:23 PM

$MLAB this is dead wow.. no movement or any meaningful activity in a while ..

0 · Reply

Estimize May. 27 at 10:09 PM

$MLAB reported 2.76 EPS and 63.72 revenue for Q4. http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_content=MLAB&utm_

0 · Reply

Arcides May. 27 at 4:11 PM

$MLAB horrible dump...

1 · Reply

CHItraders May. 27 at 12:04 PM

📊 Mesa Laboratories $MLAB Q4 Earnings ✅ Earnings Beat Adj. EPS: $3.30 (beat $0.34 est.) YoY: ↑ 46.67% (from $2.25) ❌ Revenue Miss Sales: $63.724M (missed $65.171M est.) YoY: ↑ 2.56% (from $62.135M) Mesa Laboratories delivered a massive earnings beat but missed revenue estimates this quarter.

0 · Reply

Estimize May. 6 at 10:00 AM

Wall St is expecting 1.06 EPS for $MLAB Q1 [Reporting 07/30 BMO] http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_co

0 · Reply

abeabdouh Mar. 10 at 9:51 PM

$MLAB Mesa Laboratories (NASDAQ:MLAB) Director Acquires $99,940.00 in Stock

0 · Reply

BillionerOfKing Mar. 10 at 3:23 PM

$MLAB Current Stock Price: $76.11

0 · Reply

Estimize Mar. 4 at 11:01 AM

Wall St is expecting 1.54 EPS for $MLAB Q4 [Reporting 06/02 BMO] http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_co

0 · Reply

PenkeInvesting Feb. 26 at 3:27 PM

Fundamental analysis of $MLAB (MESA LABORATORIES INC /CO/) based on financial data and reported results. #MLAB

0 · Reply

Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results

May 27, 2026, 6:00 AM EDT - 12 days ago

Mesa Laboratories Earnings release: Q4 2026

May 27, 2026, 6:00 AM EDT - 12 days ago

Mesa Laboratories Slides: Q4 2026

May 27, 2026, 6:00 AM EDT - 12 days ago

Mesa Laboratories Annual report: Q4 2026

May 5, 2026, 1:39 PM EDT - 4 weeks ago

Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026

2026-03-09T20:36:49.000Z - 3 months ago

Mesa Labs CEO Gary Owens to step down, Siddhartha Kadia to succeed

2026-02-04T11:36:50.000Z - 4 months ago

Mesa Labs price target raised to $94 from $83 at Wells Fargo

Feb 3, 2026, 8:00 AM EST - 4 months ago

Mesa Laboratories Quarterly report: Q3 2026

Feb 3, 2026, 8:00 AM EST - 4 months ago

Mesa Laboratories Earnings release: Q3 2026

Jan 14, 2026, 7:30 PM EST - 5 months ago

Mesa Laboratories Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 7:30 PM EST - 5 months ago

Mesa Laboratories Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 5:00 PM EST - 5 months ago

MESA LABS DECLARES QUARTERLY DIVIDEND

Dec 18, 2025, 7:00 PM EST - 6 months ago

Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

2025-12-15T11:31:12.000Z - 6 months ago

Mesa Labs price target raised to $83 from $75 at Wells Fargo

Nov 20, 2025, 7:00 AM EST - 7 months ago

Mesa Laboratories Transcript: Jefferies London Healthcare Conference 2025

Nov 12, 2025, 3:14 PM EST - 7 months ago

Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences

2025-11-07T19:35:22.000Z - 7 months ago

Mesa Labs price target raised to $115 from $110 at Jefferies

Nov 6, 2025, 4:00 PM EST - 7 months ago

Mesa Laboratories Quarterly report: Q2 2026

Nov 6, 2025, 4:00 PM EST - 7 months ago

Mesa Laboratories Earnings release: Q2 2026

Oct 3, 2025, 11:46 AM EDT - 8 months ago

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025

Aug 18, 2025, 2:01 PM EDT - 10 months ago

Mesa Laboratories Executes Previously-Announced Strategic Financing Plan

2025-08-07T11:00:30.000Z - 10 months ago

Mesa Labs upgraded to Equal Weight from Underweight at Wells Fargo

Aug 5, 2025, 8:00 AM EDT - 10 months ago

Mesa Labs Announces First Quarter Results

Aug 5, 2025, 8:00 AM EDT - 10 months ago

Mesa Laboratories Quarterly report: Q1 2026

Aug 5, 2025, 8:00 AM EDT - 10 months ago

Mesa Laboratories Earnings release: Q1 2026

Jul 11, 2025, 8:00 AM EDT - 11 months ago

Mesa Laboratories Proxy statement: Proxy Filing

Jul 2, 2025, 3:20 PM EDT - 1 year ago

Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025

2025-05-30T10:15:19.000Z - 1 year ago

Mesa Labs price target lowered to $100 from $120 at Wells Fargo

May 28, 2025, 8:00 AM EDT - 1 year ago

Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results

May 28, 2025, 8:00 AM EDT - 1 year ago

Mesa Laboratories Annual report: Q4 2025

May 28, 2025, 8:00 AM EDT - 1 year ago

Mesa Laboratories Earnings release: Q4 2025

Feb 4, 2025, 8:00 AM EST - 1 year ago

Mesa Labs Announces Third Quarter Results

Feb 4, 2025, 8:00 AM EST - 1 year ago

Mesa Laboratories Quarterly report: Q3 2025

Feb 4, 2025, 8:00 AM EST - 1 year ago

Mesa Laboratories Earnings release: Q3 2025

Jan 17, 2025, 1:15 PM EST - 1 year ago

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025

2024-11-12T13:20:46.000Z - 1 year ago

Mesa Labs price target lowered to $150 from $160 at Evercore ISI

Nov 7, 2024, 8:00 AM EST - 1 year ago

Mesa Labs Announces Second Quarter Results

Nov 7, 2024, 8:00 AM EST - 1 year ago

Mesa Laboratories Quarterly report: Q2 2025

Nov 7, 2024, 8:00 AM EST - 1 year ago

Mesa Laboratories Earnings release: Q2 2025

2024-10-01T12:50:30.000Z - 1 year ago

Mesa Labs target raised, added to ‘Tactical Outperform’ list at Evercore ISI

Aug 5, 2024, 8:00 AM EDT - 2 years ago

Mesa Laboratories Quarterly report: Q1 2025

Aug 5, 2024, 8:00 AM EDT - 2 years ago

Mesa Laboratories Earnings release: Q1 2025

Jul 19, 2024, 8:00 AM EDT - 2 years ago

Mesa Laboratories Proxy statement: Proxy Filing

Jun 5, 2024, 6:00 AM EDT - 2 years ago

Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results

Jun 5, 2024, 2:00 AM EDT - 2 years ago

Mesa Laboratories Annual report: Q4 2024

Jun 5, 2024, 2:00 AM EDT - 2 years ago

Mesa Laboratories Earnings release: Q4 2024

May 31, 2024, 6:00 AM EDT - 2 years ago

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results

May 22, 2024, 6:00 AM EDT - 2 years ago

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024

Apr 8, 2024, 8:00 AM EDT - 2 years ago

MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES

Apr 1, 2024, 10:27 AM EDT - 2 years ago

Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024

Mar 15, 2024, 7:00 AM EDT - 2 years ago

Mesa Labs Releases Second Annual Responsible Business Program Brochure

Feb 5, 2024, 8:00 AM EST - 2 years ago

Mesa Laboratories Quarterly report: Q3 2024

Feb 5, 2024, 8:00 AM EST - 2 years ago

Mesa Laboratories Earnings release: Q3 2024

Jan 8, 2024, 8:00 AM EST - 2 years ago

Mesa Laboratories Appoints Mark Capone to its Board of Directors

Jan 3, 2024, 8:00 AM EST - 2 years ago

Mesa Labs Completes the Acquisition of GKE Science & Technology Co.

Dec 14, 2023, 10:47 AM EST - 2 years ago

Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024

Nov 6, 2023, 7:00 AM EST - 2 years ago

Mesa Laboratories Quarterly report: Q2 2024

Nov 6, 2023, 7:00 AM EST - 2 years ago

Mesa Laboratories Earnings release: Q2 2024

Oct 16, 2023, 3:00 AM EDT - 2 years ago

Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa's SDC Platform

Sep 13, 2023, 1:37 PM EDT - 2 years ago

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023

Aug 24, 2023, 4:02 PM EDT - 3 years ago

Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions

Aug 3, 2023, 7:00 AM EDT - 3 years ago

Mesa Laboratories Quarterly report: Q1 2024

Aug 3, 2023, 7:00 AM EDT - 3 years ago

Mesa Laboratories Earnings release: Q1 2024

Jul 14, 2023, 8:00 AM EDT - 3 years ago

Mesa Laboratories Proxy statement: Proxy Filing

Jul 3, 2023, 8:00 AM EDT - 3 years ago

Mesa Laboratories Proxy statement: Proxy Filing

Jun 21, 2023, 11:50 AM EDT - 3 years ago

Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023

May 25, 2023, 8:00 AM EDT - 3 years ago

Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results

May 25, 2023, 8:00 AM EDT - 3 years ago

Mesa Laboratories Earnings release: Q4 2023

May 25, 2023, 8:00 AM EDT - 3 years ago

Mesa Laboratories Annual report: Q4 2023

Feb 5, 2023, 6:00 PM EST - 3 years ago

Mesa Laboratories Quarterly report: Q3 2023

Feb 5, 2023, 6:00 PM EST - 3 years ago

Mesa Laboratories Earnings release: Q3 2023

Jan 3, 2023, 5:00 PM EST - 3 years ago

Mesa Labs Declares Quarterly Dividend

Dec 16, 2022, 11:59 AM EST - 3 years ago

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023

Nov 17, 2022, 8:04 AM EST - 3 years ago

Mesa Labs Acquires Belyntic's Peptide Purification Business

Nov 4, 2022, 3:49 PM EDT - 3 years ago

Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director

Nov 2, 2022, 7:00 PM EDT - 3 years ago

Mesa Laboratories Quarterly report: Q2 2023

Aug 23, 2022, 8:00 AM EDT - 4 years ago

Mesa Laboratories Proxy statement: Proxy Filing

Aug 22, 2022, 8:00 AM EDT - 4 years ago

Mesa Laboratories Proxy statement: Proxy Filing

Aug 3, 2022, 6:00 PM EDT - 4 years ago

Mesa Laboratories Quarterly report: Q1 2023

Jul 14, 2022, 8:00 AM EDT - 4 years ago

Mesa Laboratories Proxy statement: Proxy Filing

Jun 27, 2022, 8:01 AM EDT - 4 years ago

Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

May 31, 2022, 8:00 AM EDT - 4 years ago

Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results

May 30, 2022, 6:00 PM EDT - 4 years ago

Mesa Laboratories Earnings release: Q4 2022

May 30, 2022, 6:00 PM EDT - 4 years ago

Mesa Laboratories Annual report: Q4 2022

Feb 2, 2022, 6:00 PM EST - 4 years ago

Mesa Laboratories Quarterly report: Q3 2022

Nov 3, 2021, 7:00 PM EDT - 4 years ago

Mesa Laboratories Quarterly report: Q2 2022

Oct 20, 2021, 12:05 PM EDT - 5 years ago

Mesa Labs Closes Acquisition of Agena Bioscience

Sep 14, 2021, 7:00 AM EDT - 5 years ago

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

Aug 3, 2021, 6:00 PM EDT - 5 years ago

Mesa Laboratories Quarterly report: Q1 2022

Aug 3, 2021, 6:00 PM EDT - 5 years ago

Mesa Laboratories Earnings release: Q1 2022

Jul 16, 2021, 8:00 AM EDT - 5 years ago

Mesa Laboratories Proxy statement: Proxy Filing

May 31, 2021, 6:00 PM EDT - 5 years ago

Mesa Laboratories Earnings release: Q4 2021

May 31, 2021, 6:00 PM EDT - 5 years ago

Mesa Laboratories Annual report: Q4 2021

Feb 3, 2021, 8:00 AM EST - 5 years ago

Mesa Labs Reports Third Quarter Results for FY21

Feb 2, 2021, 6:00 PM EST - 5 years ago

Mesa Laboratories Quarterly report: Q3 2021

Nov 5, 2020, 8:00 AM EST - 6 years ago

Mesa Labs Reports Second Quarter Results for FY21

Nov 4, 2020, 6:00 PM EST - 6 years ago

Mesa Laboratories Quarterly report: Q2 2021

Aug 20, 2020, 8:00 AM EDT - 6 years ago

Mesa Laboratories Proxy statement: Proxy Filing

Aug 6, 2020, 8:00 AM EDT - 6 years ago

Mesa Labs Reports First Quarter Results

Aug 5, 2020, 6:00 PM EDT - 6 years ago

Mesa Laboratories Quarterly report: Q1 2021

Jul 17, 2020, 8:00 AM EDT - 6 years ago

Mesa Laboratories Proxy statement: Proxy Filing

Jun 16, 2020, 11:52 AM EDT - 6 years ago

Mesa Laboratories, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering

Jun 9, 2020, 8:15 PM EDT - 6 years ago

Mesa Laboratories, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock

Jun 8, 2020, 4:01 PM EDT - 6 years ago

Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock

Jun 1, 2020, 8:00 AM EDT - 6 years ago

Mesa Laboratories Annual report: Q4 2020

May 15, 2020, 8:00 AM EDT - 6 years ago

Life Sciences Executive Shannon Hall Joins Mesa Labs Board of Directors

Jan 9, 2020, 7:00 PM EST - 6 years ago

MESA LABS DECLARES QUARTERLY DIVIDEND

Oct 31, 2019, 8:55 PM EDT - 7 years ago

Mesa Labs Acquires Gyros Protein Technologies

d_risk Jun. 4 at 2:38 PM

0 · Reply

Quadruple_Double Jun. 1 at 4:23 PM

$MLAB this is dead wow.. no movement or any meaningful activity in a while ..

0 · Reply

Estimize May. 27 at 10:09 PM

$MLAB reported 2.76 EPS and 63.72 revenue for Q4. http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_content=MLAB&utm_

0 · Reply

Arcides May. 27 at 4:11 PM

$MLAB horrible dump...

1 · Reply

CHItraders May. 27 at 12:04 PM

0 · Reply

Estimize May. 6 at 10:00 AM

Wall St is expecting 1.06 EPS for $MLAB Q1 [Reporting 07/30 BMO] http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_co

0 · Reply

abeabdouh Mar. 10 at 9:51 PM

$MLAB Mesa Laboratories (NASDAQ:MLAB) Director Acquires $99,940.00 in Stock

0 · Reply

BillionerOfKing Mar. 10 at 3:23 PM

$MLAB Current Stock Price: $76.11

0 · Reply

Estimize Mar. 4 at 11:01 AM

Wall St is expecting 1.54 EPS for $MLAB Q4 [Reporting 06/02 BMO] http://www.estimize.com/intro/mlab?chart=historical&metric_name=eps&utm_co

0 · Reply

PenkeInvesting Feb. 26 at 3:27 PM

Fundamental analysis of $MLAB (MESA LABORATORIES INC /CO/) based on financial data and reported results. #MLAB

0 · Reply

SuperGreenToday Feb. 25 at 3:28 PM

$MLAB

0 · Reply

IdaLarsen905 Feb. 18 at 1:40 PM

$MLAB Diagnostic instruments firm with steady demand.

0 · Reply

DylanHarman593 Feb. 11 at 3:52 PM

$MLAB Mesa Labs; life sciences tools (sterilization monitoring); steady grower; tied to biopharma and healthcare capital spending.

0 · Reply

IN0V8 Feb. 4 at 7:45 PM

$MLAB Wells Fargo raises target price to $94 from $83

0 · Reply

BillionerOfKing Jan. 16 at 5:09 AM

$MLAB Current Stock Price: $87.66

0 · Reply

BearTamerTrading Jan. 11 at 11:57 PM

On Watch for JPM Week: Part 2 $MLAB – Mesa Labs – will present on Jan 14, 2026. $AAPG – Ascentage Pharma Group International – announced presentation. $LFCR – Lifecore Biomedical – participating (1-on-1s and meetings).

0 · Reply

ProximityPro Dec. 26 at 2:23 PM

$MLAB Market structure is quietly punishing unfocused strategies. Efficiency initiatives must translate into measurable productivity. Evidence of repeatability is likely to change market tone. Stronger outcomes appear only when priorities stay focused.

0 · Reply

JarvisFlow Dec. 15 at 6:27 PM

Wells Fargo has adjusted their stance on Mesa Laboratories ( $MLAB ), setting the rating to Equal-Weight with a target price of 75 → 83.

0 · Reply

Market Cap	573.98M
Revenue (ttm)	249.13M
Net Income (ttm)	6.71M
EPS (ttm)	N/A
PE Ratio	15.98
Forward PE	12.49
Profit Margin	2.69%
Debt to Equity Ratio	0.00

Volume	181,400
Avg Vol	143,220
Day's Range	N/A - N/A
Shares Out	5.53M
Stochastic %K	93%
Beta	0.94
Analysts	Sell
Price Target	$112.00